Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: an NYGOG and ECOG study.
Hochster HS, Plimack ER, Mandeli J, Wadler S, Runowicz C, Goldberg G, Speyer J, Wallach R, Muggia F; New York Gynecologic Oncology Group (and phase II consortium) and the Eastern Cooperative Oncology. Hochster HS, et al. Among authors: wadler s. Gynecol Oncol. 2006 Feb;100(2):324-9. doi: 10.1016/j.ygyno.2005.08.059. Epub 2005 Oct 25. Gynecol Oncol. 2006. PMID: 16253316 Clinical Trial.
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.
Pavlick AC, Wu J, Roberts J, Rosenthal MA, Hamilton A, Wadler S, Farrell K, Carr M, Fry D, Murgo AJ, Oratz R, Hochster H, Liebes L, Muggia F. Pavlick AC, et al. Among authors: wadler s. Cancer Chemother Pharmacol. 2009 Sep;64(4):803-10. doi: 10.1007/s00280-009-0931-y. Epub 2009 Feb 17. Cancer Chemother Pharmacol. 2009. PMID: 19221754 Free PMC article. Clinical Trial.
A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer.
Hochster H, Speyer JL, Mandeli JP, Runowicz C, Wadler S, Berk G, Wallach R, Holland JF. Hochster H, et al. Among authors: wadler s. Gynecol Oncol. 1999 Mar;72(3):292-7. doi: 10.1006/gyno.1998.5261. Gynecol Oncol. 1999. PMID: 10053098 Free article. Clinical Trial.
178 results